MedTrace Logo

Serum Sphingolipidomic Analyses in Healthy, Diabetic and Prediabetic Subjects

NCT02826759 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2016-07-11

No results posted yet for this study

Summary

This study is designed to compare the serum sphingolipidomic analyses in healthy, pre-diabetic and diabetic subjects. age, sex and BMI are matched among these three groups. As ceramide, sphingosine, sphingosine-1-phosphate and sphinganine are involved in inflammation, immunity and cancer, investigators proposed a hypothesis that sphingosine-1-phosphate and other sphingolipids may be associated with the progress of type 2 diabetes. sphingolipids may be a biomarker for diabetes.

Conditions

  • Diabetes Mellitus, Type 2
  • Prediabetic State

Interventions

OTHER

diabetes

the exposure of interests are obesity, diabetes and insulin-resistance

Sponsors & Collaborators

  • Chinese Medical Association

    collaborator NETWORK

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Jing Sui · First Affiliated Hospital Xi'an Jiaotong University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02826759 on ClinicalTrials.gov